AlphaQ Advisors LLC Purchases New Shares in HealthEquity, Inc. (NASDAQ:HQY)

AlphaQ Advisors LLC acquired a new position in shares of HealthEquity, Inc. (NASDAQ:HQY) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 3,265 shares of the company’s stock, valued at approximately $313,000. HealthEquity accounts for about 0.9% of AlphaQ Advisors LLC’s holdings, making the stock its 26th biggest holding.

A number of other hedge funds have also bought and sold shares of the company. Wealthfront Advisers LLC purchased a new position in HealthEquity during the 4th quarter valued at $10,304,089,000. Vanguard Group Inc. boosted its stake in HealthEquity by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 8,976,091 shares of the company’s stock valued at $861,256,000 after acquiring an additional 99,624 shares in the last quarter. FMR LLC grew its holdings in HealthEquity by 2.4% in the fourth quarter. FMR LLC now owns 5,415,800 shares of the company’s stock worth $519,646,000 after purchasing an additional 125,684 shares during the last quarter. Geode Capital Management LLC increased its position in shares of HealthEquity by 0.5% during the fourth quarter. Geode Capital Management LLC now owns 2,089,398 shares of the company’s stock worth $200,522,000 after purchasing an additional 10,421 shares in the last quarter. Finally, Brown Advisory Inc. lifted its holdings in shares of HealthEquity by 12.0% during the 4th quarter. Brown Advisory Inc. now owns 2,086,026 shares of the company’s stock valued at $200,154,000 after purchasing an additional 224,016 shares during the last quarter. Institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Up 3.7%

HQY stock opened at $101.18 on Wednesday. The company has a market capitalization of $8.75 billion, a P/E ratio of 92.83, a price-to-earnings-growth ratio of 1.60 and a beta of 0.45. HealthEquity, Inc. has a 12 month low of $65.01 and a 12 month high of $115.59. The firm’s fifty day simple moving average is $88.06 and its 200-day simple moving average is $97.23. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20.

Analyst Ratings Changes

Several research analysts recently issued reports on HQY shares. KeyCorp reduced their target price on HealthEquity from $110.00 to $100.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 16th. The Goldman Sachs Group dropped their price target on HealthEquity from $107.00 to $94.00 and set a “neutral” rating on the stock in a research note on Thursday, March 27th. Raymond James raised shares of HealthEquity from an “outperform” rating to a “strong-buy” rating and decreased their price objective for the company from $120.00 to $115.00 in a research report on Tuesday, March 25th. Wells Fargo & Company lifted their target price on shares of HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 26th. Finally, Barrington Research restated an “outperform” rating and set a $112.00 price target on shares of HealthEquity in a research note on Friday, April 11th. One investment analyst has rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, HealthEquity has a consensus rating of “Buy” and an average price target of $111.75.

Insider Buying and Selling

In other news, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction that occurred on Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total transaction of $446,487.50. Following the completion of the transaction, the director now directly owns 84,969 shares of the company’s stock, valued at $6,597,842.85. This represents a 6.34% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, EVP Michael Henry Fiore sold 8,881 shares of the stock in a transaction that occurred on Friday, April 4th. The shares were sold at an average price of $78.26, for a total value of $695,027.06. Following the transaction, the executive vice president now owns 56,655 shares in the company, valued at $4,433,820.30. This trade represents a 13.55% decrease in their position. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by insiders.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.